AHA Urges Biden to Provide Strong Federal Leadership on COVID-19 Vaccine Distribution and Administration
Letters
Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.
Latest
The Medicare Payment Advisory Commission (MedPAC, or the Commission) will vote this month on payment recommendations for 2022.
AHA comments on the Centers for Medicare & Medicaid Services’ proposed changes to the hospital and hospital health care complex cost report.
AHA letter urging HHS to exercise enforcement discretion with respect to the hospital price transparency rule.
AHA letter to HHS outlining leadership actions needed to expedite the administration of covid-19 vaccines.
AHA urges the Department of Health and Human Services’ Office of the National Coordinator for Health Information Technology to extend the deadline to comply with its final rule implementing information blocking provisions of the 21st Century Cures Act to 2022 or six months after the end of the COVID-19 public health emergency, whichever is later. The current deadline is April 5, 2021.
AHA comments on CMS’ proposed rule on prior authorization.
AHA comments on the Centers for Medicare & Medicaid Services’ (CMS) proposed Notice of Benefit and Payment Parameters for 2022.
AHA comments on the Centers for Medicare & Medicaid Services’ hospital outpatient prospective payment system and ambulatory surgical center payment system final rule with comment period for calendar year 2021.
The AHA submitted comments to a Centers for Medicare & Medicaid Services request for information on regulatory relief to support economic recovery. Specifically, AHA urged the agency to take additional action to remove certain regulatory barriers standing in the way of efficiency and innovation, thus allowing hospitals to provide better and more cost-effective care to our patients and communities. In order to achieve these objectives, we ask the agency to temporarily extend certain waivers and make others permanent beyond the duration of the COVID-19 public health emergency.